HomeFinancial MarketsFutures Slip as Big Pharma Earnings Roll In

Futures Slip as Big Pharma Earnings Roll In

Futures in New York edged lower on Tuesday following the latest influx of earnings from major pharmaceutical companies. Investors also remain focused on incoming economic data to better understand the trajectory of the U.S. economy.

Dow Jones e-minis declined by 51 points, or 0.14%, while S&P 500 e-minis fell by 7.25 points or 0.16%. Nasdsaq 100 e-minis fell by 32.5 points or 0.2%. This comes after the benchmark S&P 500 index hit a more than 15-month high on Monday. The index is now just 4.7% away from reaching its record intraday high on January 4, 2022.

Merck stock rose by 1.4% in premarket trading when the big pharma company raised its full-year profit forecast after beating analysts’ second-quarter estimates. Computing company Arista Networks jumped by 14.8% after beating its own Q2 earnings forecast, driven by demand for its cloud networking products.

Investors now await the ISM Manufacturing survey to assess U.S. factory activity in July. The Labor Department’s Job Openings and Labor Turnover Survey is also in the pipeline.

McDonald’s Reports Mixed Q1 Results, Misses on Sales Estimates

Fast food enthusiasts haven’t been flocking to McDonald’s in the first quarter of 2024 in the manner the company expected. Sharing its quarterly result,...

Blackstone Reaches $1.6 Billion Takeover Agreement for Hipgnosis Songs

Alternative investment management company Blackstone has reached an agreement to acquire Hipgnosis Songs, a song management fund that owns the music catalog rights of...

Troubled Republic First Bancorp Seized By Regulators, Sold to Fulton Bank

Pennsylvania-based Republic First Bancorp became the first U.S. bank to fold in 2024. The state regulators closed Republic First earlier this week and appointed...